| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
8e-09 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-07 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-06 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-06 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |